$3.43
0.072.08%
Last update: Oct 9, 6:11 PM
GoodRx Holdings Inc
GDRXNASDAQ
GoodRx Holdings (GDRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GoodRx Holdings (GDRX) last issued guidance on August 5, 2026 for fiscal year 2026. The company guided revenue in the range of $790M - $805M for the period.
Compared to prior guidance, GoodRx Holdings raised its revenue forecast from a prior range of $765M - $785M.
GoodRx Holdings has issued 25 guidance updates between November 8, 2022 and August 5, 2026. During this period, the company raised its outlook 8 times and lowered it 10 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.07 | $0.06 | $0.07 | $0.07 |
| Actual | $0.08 | $0.07 | $0.09 | $0.08 |
| Surprise | +14.3% | +16.7% | +28.6% | +14.3% |
| Revenue | ||||
| Estimate | $193.1M | $184.1M | $192.8M | $194.1M |
| Actual | $200.4M | $194.0M | $194.8M | $196.0M |
| Surprise | +3.79% | +5.37% | +1.04% | +1.01% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.07 | $0.07 | $0.05 | $0.05 |
| Revenue | ||||
| Consensus | $202.1M | $202.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.08 | $0.07 | 14.3 % |
| Q1 | May 6, 2026 | $0.07 | $0.06 | 16.7 % |
| Q4 | Feb 25, 2026 | $0.09 | $0.07 | 28.6 % |
| Q3 | Nov 4, 2025 | $0.08 | $0.07 | 14.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $200.41M | $193.10M | 3.79 % |
| Q1 | May 6, 2026 | $194.01M | $184.11M | 5.37 % |
| Q4 | Feb 25, 2026 | $194.79M | $192.78M | 1.04 % |
| Q3 | Nov 4, 2025 | $196.03M | $194.08M | 1.01 % |
